논문KCI 등재후보
Osteopenia - When, How Long and Whom to Treat?
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
주제분류기타의약학
초록
Osteopenia or low bone mass is defined as T-Score between -1 and -2.5. The clinical translation of Osteopenia is two fold increase in fracture risk. Osteopenia along with other clinical risk factors increase the likelihood of osteoporotic fractures.
Abstract
Osteopenia or low bone mass is defined as T-Score between -1 and -2.5. The clinical translation of Osteopenia is two fold increase in fracture risk. Osteopenia along with other clinical risk factors increase the likelihood of osteoporotic fractures.
참고문헌 (28)
- Looker AC, "Prevalence of low femoral bone density in older U.S. adults from NHANES III", J Bone Miner Res, 12, pp.1761~1768 (1997)
- Siris ES, "Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the National Osteoporosis Risk Assessment", JAMA, 286, pp.2815~2822 (2001)
- Melton LJ 3rd, "Hip fractures: A worldwide problem today and tomorrow", Bone Bone, 14(Suppl 1), pp.1~8 (1993)
- Joshi VR, "Osteoporosis--approach in Indian scenario", J Assoc Physicians India, 46, pp.965~967 (1998)
- Shah Rashmi, "Spinal bone mineral density in normal Indian Females", J bone Mineral Res, 13, pp.121~132 (1998)
- Pande KC, "Digital X-ray, radiogramatory establishment and comparision of Indian female & male normative reference data", J Bone Mineral Res, 16, pp.276~279 (2001)
- Donaldson LJ, "Incidence of fractures in a geographically defined population", J Epidemiodal Community Health, 44, pp.241~245 (1990)
- Jones G, "Symptomatic fractures incidence in elderly men and wome: the Dubbo Osteoporosis Epidemiology Study (DOES)", Osteoporosis Int, 3, pp.277~282 (1994)
- Melton LJ 3rd, "Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time", Osteoporos Int, 9, pp.29~37 (1999)
- Black DM, "For the Fracture Intervention Trial Research Group. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures", Lancet, 348, pp.1535~1541 (1996)
- Cummings SR, "Effect of alendronate on risk of fracture in women with low bone density but without vertebral fracture. Results from the Fracture Intervention Trial", JAMA, 280, pp.22~26 (1998)
- Chesnut 111 CH, "OralIbandronate osteoporosis vertebral Fracture Trial in north America and Europe (BONE). Effect of oral ibandronate administered daily or intermittently on fracture risk and post menopausal women", J Bone Miner Res, 19, pp.1241~1249 (2004)
- Black DM, "HORIZON Pivotal Fracture Trial. Once yearly Zoledronic acid for treatment of post menopausal osteoporosis", New Engl J Med, 356, pp.1809~1822 (2007)
- Black DM, "Reduction of vertebral fracture risk in post menopausal Ettinger women with osteoporosis treated with raloxifine:results from a three year randomized clinical trial. Multiple Outcomes of Raloxifine Evaluation (ORE) investigators", JAMA, 282, pp.637~645 (1999)
- Cauley JA, "Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial", JAMA, 290, pp.1729~1738 (2003)
- Gallagher JC, "Teriparatide reduces the fracture risk associated with increasing in number and severity of osteoporotic fracture", J Clin Endocrinol Metab, 90, pp.1583~1587 (2005)
- Hodsman AB, "Efficacy and safety of Human parathyroid Hormone (1-84) in increasing bone mineral density in post menopausal osteoporosis", J Clin Endocrinol Metab, 88, pp.5212~5220 (2003)
- Ishida Y, "Comparitive efficacy of hormone replacement therapy, etidronate, calcitonin, alpha calcitol in post menopausal women with osteoporosis. The Yamaguchi Osteoporosis Prevention Study", Am J Med, 117, pp.549~555 (2004)
- Cranney A, "Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analysis for post menopausal osteoporosis. Meta-analysis of calcitonin for the treatment of post menopausal osteoporosis", Endocr Rev, 23, pp.540~551 (2002)
- MacLean C, "Systemic review: comparative effectiveness of treatments to prevent fractures in men and womenwith low bone density or osteoporosis", Ann Intern Med, 148, pp.1972~ (2008)
- Tang BM, "Use of Calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A Meta-Analysis", Lancet, 372, pp.657~666 (2007)
- Grant Am, "RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low trauma fractures in elderly people: randomized placebo control trial", Lancet, 365, pp.1621~1628 (2005)
- "FRAX- WHO Fracture Risk Assessment Tool"[URL]
- "Foundation for Osteoporosis Research and Educative Guidelines for Care for the Primary Care Physician"[URL]
- "Royal College for physician- Osteoporosis-Clinical guidelines for prevention and treatment"[URL]
- "The Journal of the North American Menopause Society", 14(3), pp.340~367
- "Asia Pacific Menopause Federation Consensus statement 2008. Vietnam", ~ (2008)
- "Indian Menopause Society Consensus Guidelines 2006. Delhi", ~ (2006)
관련 논문AI추천
Beyond the T-Score: Individualized Fracture Prevention in OsteopeniaJi Yeon Han대한폐경학회 · 대한폐경학회지2025 · 제31권 제3호Individualized Fracture Prevention for Postmenopausal Women with OsteopeniaJaeyen Song, Jisu Mun, Junghyun Park, Jungyoon Park, Meeran Kim, Younjee Chung대한폐경학회 · 대한폐경학회지2025 · 제31권 제3호Osteoporosis in Men and Women: The Current Perspectives on Prevention and TreatmentKo-En Huang대한골다공증학회 · OSTEOPOROSIS2009 · 제7권 제2호Physicians’ Attitudes on Management of Osteopenia in South Korea구경회, 이영균, Hong Seok Kim, Joo Hyung Ha, Samuel Jaeyoon Won대한골대사학회 · 대한골대사학회지2020 · 제27권 제3호Treatment of Osteoporosis: Unmet Needs and Emerging SolutionsBente Lomholt Langdahl, Jane Dahl Andersen대한골대사학회 · 대한골대사학회지2018 · 제25권 제3호Up-to-Date Knowledge on Osteoporosis Treatment Selection in Postmenopausal WomenHee Jeung Lim, Hye Gyeong Jeong, Min Kyung Kim, Seul Ki Kim대한폐경학회 · 대한폐경학회지2022 · 제28권 제3호
이 간행물의 다른 논문 (9건)
The Situation of Osteoporosis in Thailand: Update for 2010Pongsak Yuktanandana, Khunying Kobchitt Limpaphayompp. 9-14Osteoporosis and Fracture among Patients with Type 1 and Type 2 Diabetes박은주, 홍서유pp. 15-25Effects of Combined Estrogen and Effervescent Fluocalcic Therapy on the Bone Mineral Density and Bone Metabolism of Surgical Menopause Women with Osteopenia공은희, 이지영, 정민형, 김흥열, 주일우, 최훈pp. 26-37폐경 전 여성에서 무월경과 골밀도와의 관계김성훈, 김정훈, 강병문, 전균호, 김소라, 채희동pp. 38-46조골세포에서 Rosiglitazone에 의한 RANKL과 OPG의 발현 조절이수연, 박상현, 이명주, 안도환pp. 47-55
